Iovance Biotherapeutics
Price & Volume
Stats
See more52W Range | $2.08-$15.37 |
Market Cap | $3.6B |
Shares Short | 58M |
Financials
See moreRevenue (12 Mos) | $324.9M |
Revenue Growth (YoY) | 65.7% |
Gross Profit (12 Mos) | $157.2M |
Diluted EPS | -$0.69 |
News
See moreYahoo Finance • 3 days ago
Quant snapshot: Iovance Biotherapeutics and DiamondRock Hospitality Company lead top-rated names as Intact Financial and Fiserv Payments lag
Yahoo Finance • 5 days ago
Iovance Biotherapeutics (IOVA) Posts 59.1% Response In Lifileucel Lung Cancer Study
Yahoo Finance • last month
Biotech ETFs to Buy as Cancer Drug Breakthroughs Accelerate
Yahoo Finance • 2 months ago
4 Biotech Stocks to Watch as Potential Takeover Targets
About
CEO | Dr. Frederick G. Vogt Esq., J.D., Ph.D. |
Address | 300 Rouse Blvd., Philadelphia, PA, United States, 19112 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 975 |